Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-nitro-4'-isothiocyanodiphenyl Ether
2. Gs 23654
3. Lapatol
1. 19881-18-6
2. 4-isothiocyanato-4'-nitrodiphenyl Ether
3. Cantrodifene
4. Lopatol
5. Benzene, 1-isothiocyanato-4-(4-nitrophenoxy)-
6. 1-isothiocyanato-4-(4-nitrophenoxy)benzene
7. P-(p-nitrophenoxy)phenyl Isothiocyanate
8. Cga-23654
9. P4ie5b6d6u
10. Ncgc00182049-01
11. Nitroscanato
12. Nitroscanatum
13. Nitroscanatum [inn-latin]
14. Nitroscanato [inn-spanish]
15. Ccris 7198
16. Einecs 243-393-6
17. Cga 23654
18. Unii-p4ie5b6d6u
19. 4-(4-nitrophenoxy)phenyl Isothiocyanat
20. Brn 0888706
21. Gs 23654
22. Nitroscanate [usan:inn:ban]
23. Isothiocyanic Acid, P-(p-nitrophenoxy)phenyl Ester
24. Nitroscanate [mi]
25. Benzene,1-isothiocyanato-4-(4-nitrophenoxy)-
26. Nitroscanate (usan/inn)
27. Nitroscanate [inn]
28. Nitroscanate [usan]
29. Dsstox_cid_28698
30. Dsstox_rid_82967
31. Dsstox_gsid_48772
32. Nitroscanate [mart.]
33. Schembl381451
34. Chembl304432
35. Zinc1821
36. Dtxsid9048772
37. Tox21_113247
38. Mfcd00060545
39. Akos030236754
40. Ncgc00182049-02
41. 4-(4-nitrophenyloxy)-phenylisothiocyanate
42. 4-isothiocyanato-4\'-nitrodiphenyl Ether
43. 1-(4-isothiocyanatophenoxy)-4-nitrobenzene
44. Cas-19881-18-6
45. Db-045016
46. Ft-0608316
47. 1-(4-isothiocyanatophenoxy)-4-nitrobenzene #
48. D05193
49. Sr-01000944851
50. 4-isothiocyanato-4'-nitrodiphenyl Ether, Aldrichcpr
51. J-012840
52. Q7041503
53. Sr-01000944851-1
| Molecular Weight | 272.28 g/mol |
|---|---|
| Molecular Formula | C13H8N2O3S |
| XLogP3 | 5.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 272.02556330 g/mol |
| Monoisotopic Mass | 272.02556330 g/mol |
| Topological Polar Surface Area | 99.5 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 349 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Nitroscanate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitroscanate, including repackagers and relabelers. The FDA regulates Nitroscanate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitroscanate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nitroscanate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nitroscanate supplier is an individual or a company that provides Nitroscanate active pharmaceutical ingredient (API) or Nitroscanate finished formulations upon request. The Nitroscanate suppliers may include Nitroscanate API manufacturers, exporters, distributors and traders.
click here to find a list of Nitroscanate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nitroscanate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nitroscanate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nitroscanate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nitroscanate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nitroscanate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nitroscanate suppliers with NDC on PharmaCompass.
Nitroscanate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitroscanate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitroscanate GMP manufacturer or Nitroscanate GMP API supplier for your needs.
A Nitroscanate CoA (Certificate of Analysis) is a formal document that attests to Nitroscanate's compliance with Nitroscanate specifications and serves as a tool for batch-level quality control.
Nitroscanate CoA mostly includes findings from lab analyses of a specific batch. For each Nitroscanate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitroscanate may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitroscanate EP), Nitroscanate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitroscanate USP).
LOOKING FOR A SUPPLIER?
